Novigenix AI
PrivateLast Round
Grant
Mar 31, 2025
Total Funding Raised
$25.99M
Company Overview
Novigenix AI operates in Healthcare & Life Sciences and is based in Epalinges. Its latest recorded funding round was a Grant round in March 2025.
Novigenix AI is a Swiss precision medicine company developing immuno-transcriptomic solutions for early cancer detection, therapy optimization, and disease monitoring.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novigenix AI Comparables
Compare Novigenix AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cofactor Genomics | 84% | |
| Nine Diagnostics | 81% | |
| Immunai | 79% |
For institutional investors. Book with your work email.
Novigenix AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 31, 2025 | ||||
| Grant | Sep 24, 2024 | ||||
| Series B | Nov 15, 2022 | ||||
| Grant | Dec 22, 2020 | ||||
| Grant | Jan 21, 2020 | ||||
Series A Extension | Jan 18, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Novigenix AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Initiative Capital Romandie | Series A Extension |
| Innovative Health Initiative | Grant |
| Maastricht University | Grant |
| NeoMed Management | Series A Extension |
| Eurostars SME programme | Grant |
| KU Leuven | Grant |
| Radboud University | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 340% MoM, reaching 1.6K.
- Jun 2, 2025
Monthly visitors grew 54% from 1.3K to 2K.
For institutional investors. Book with your work email.
Novigenix AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novigenix AI's valuation, stock price, and market status.
Is Novigenix AI a public or private company?
Novigenix AI is a private company.
What is the current stock price of Novigenix AI?
Novigenix AI is a private company, so its shares have no public market price. Caplight tracks Novigenix AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novigenix AI worth (valuation)?
Valuation information for Novigenix AI is not publicly available.
Can I buy Novigenix AI stock?
Novigenix AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novigenix AI's last funding round?
Novigenix AI's most recent funding round was Grant on March 31, 2025.
Who are the main investors in Novigenix AI?
Key investors in Novigenix AI include Initiative Capital Romandie, Innovative Health Initiative, Maastricht University, NeoMed Management, Eurostars SME programme.
Will Novigenix AI IPO soon?
No public IPO plans have been announced for Novigenix AI.
How can I track Novigenix AI secondary market activity?
Caplight tracks bids, offers, and trades in Novigenix AI's shares on secondary markets.